Reflect Scientific Stock Price To Earning
| RSCF Stock | USD 0.05 0.01 18.33% |
Reflect Scientific fundamentals help investors to digest information that contributes to Reflect Scientific's financial success or failures. It also enables traders to predict the movement of Reflect OTC Stock. The fundamental analysis module provides a way to measure Reflect Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Reflect Scientific otc stock.
Reflect |
Reflect Scientific OTC Stock Price To Earning Analysis
Reflect Scientific's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Reflect Scientific Price To Earning | 8.47 X |
Most of Reflect Scientific's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Reflect Scientific is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Reflect Scientific has a Price To Earning of 8.47 times. This is 67.22% lower than that of the Life Sciences Tools & Services sector and 76.7% lower than that of the Health Care industry. The price to earning for all United States stocks is 70.51% higher than that of the company.
Reflect Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Reflect Scientific's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Reflect Scientific could also be used in its relative valuation, which is a method of valuing Reflect Scientific by comparing valuation metrics of similar companies.Reflect Scientific is currently under evaluation in price to earning category among its peers.
Reflect Fundamentals
| Return On Equity | 0.25 | |||
| Return On Asset | 0.14 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.21 % | |||
| Current Valuation | 4.84 M | |||
| Shares Outstanding | 84.99 M | |||
| Shares Owned By Insiders | 53.69 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Earning | 8.47 X | |||
| Price To Book | 2.59 X | |||
| Price To Sales | 2.25 X | |||
| Revenue | 2.81 M | |||
| Gross Profit | 1.93 M | |||
| EBITDA | 996.22 K | |||
| Net Income | 939.07 K | |||
| Cash And Equivalents | 1.25 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 86.4 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 9.25 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | 831.38 K | |||
| Beta | 2.24 | |||
| Market Capitalization | 5.52 M | |||
| Total Asset | 2.48 M | |||
| Retained Earnings | (19.43 M) | |||
| Working Capital | 436.45 K | |||
| Current Asset | 622.72 K | |||
| Current Liabilities | 186.27 K | |||
| Z Score | 29.0 | |||
| Net Asset | 2.48 M |
About Reflect Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Reflect Scientific's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reflect Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reflect Scientific based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| CART | Maplebear Common Stock | |
| OPK | Opko Health | |
| AVAI | Avant Technologies | |
| VEOEY | Veolia Environnement SA | |
| GOOG | Alphabet Inc Class C |
Other Information on Investing in Reflect OTC Stock
Reflect Scientific financial ratios help investors to determine whether Reflect OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Reflect with respect to the benefits of owning Reflect Scientific security.